masoprocol and Carcinoma, Small Cell

masoprocol has been researched along with Carcinoma, Small Cell in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bunjobpon, W; Fessler, S; Freer, IK; Glaser, M; Liu, T; McDonald, RW; Pardo, OE; Robins, DJ; Seckl, MJ1
Avis, IM; Boyle, T; Jett, M; Martínez, A; Moody, T; Mulshine, JL; Treston, AM; Vos, MD1

Other Studies

2 other study(ies) available for masoprocol and Carcinoma, Small Cell

ArticleYear
Synthesis and anticancer activity of nordihydroguaiaretic acid (NDGA) and analogues.
    Anti-cancer drug design, 2001, Volume: 16, Issue:6

    Topics: Antineoplastic Agents; Carcinoma, Small Cell; Cell Division; Humans; Inhibitory Concentration 50; Lipoxygenase Inhibitors; Lung Neoplasms; Masoprocol; Oxidation-Reduction; Structure-Activity Relationship; Tumor Cells, Cultured

2001
Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling.
    The Journal of clinical investigation, 1996, Feb-01, Volume: 97, Issue:3

    Topics: 5-Lipoxygenase-Activating Proteins; Animals; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Base Sequence; Carcinoma, Small Cell; Carrier Proteins; Cell Division; Gastrin-Releasing Peptide; Growth Substances; Lipoxygenase Inhibitors; Lung Neoplasms; Masoprocol; Membrane Proteins; Mice; Mice, Nude; Molecular Sequence Data; Peptides; RNA, Messenger; Signal Transduction; Somatomedins

1996